HighTower Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.39M Buy
49,196
+16,163
+49% +$786K ﹤0.01% 1471
2025
Q1
$1.12M Buy
33,033
+1,325
+4% +$45.1K ﹤0.01% 1878
2024
Q4
$1.25M Sell
31,708
-6,608
-17% -$260K ﹤0.01% 1810
2024
Q3
$1.79M Sell
38,316
-1,349
-3% -$63.1K ﹤0.01% 1581
2024
Q2
$2.15M Sell
39,665
-2,908
-7% -$157K ﹤0.01% 1411
2024
Q1
$2.9M Buy
42,573
+5,043
+13% +$343K ﹤0.01% 1236
2023
Q4
$2.36M Sell
37,530
-2,465
-6% -$155K ﹤0.01% 1347
2023
Q3
$1.81M Sell
39,995
-36
-0.1% -$1.63K ﹤0.01% 1431
2023
Q2
$2.25M Sell
40,031
-228
-0.6% -$12.8K ﹤0.01% 1285
2023
Q1
$1.82M Buy
40,259
+9,747
+32% +$441K ﹤0.01% 1340
2022
Q4
$1.23M Sell
30,512
-4,898
-14% -$198K ﹤0.01% 1549
2022
Q3
$2.32M Buy
35,410
+1,421
+4% +$93.1K 0.01% 1151
2022
Q2
$2.06M Sell
33,989
-15,894
-32% -$964K 0.01% 1241
2022
Q1
$3.13M Buy
49,883
+16,494
+49% +$1.03M 0.01% 1120
2021
Q4
$2.54M Sell
33,389
-9,770
-23% -$744K 0.01% 1224
2021
Q3
$4.83M Buy
43,159
+3,006
+7% +$336K 0.01% 833
2021
Q2
$6.49M Buy
40,153
+10,668
+36% +$1.73M 0.02% 702
2021
Q1
$3.58M Buy
29,485
+3,014
+11% +$366K 0.01% 859
2020
Q4
$4.05M Buy
26,471
+1,497
+6% +$229K 0.02% 653
2020
Q3
$2.09M Sell
24,974
-385
-2% -$32.2K 0.01% 857
2020
Q2
$1.86M Buy
25,359
+4,809
+23% +$353K 0.01% 832
2020
Q1
$873K Buy
20,550
+1,850
+10% +$78.6K 0.01% 1067
2019
Q4
$1.13M Buy
18,700
+1,075
+6% +$65.1K 0.01% 1083
2019
Q3
$722K Sell
17,625
-5,043
-22% -$207K ﹤0.01% 1341
2019
Q2
$1.07M Buy
22,668
+2,523
+13% +$119K 0.01% 1161
2019
Q1
$721K Buy
20,145
+3,453
+21% +$124K ﹤0.01% 1278
2018
Q4
$480K Sell
16,692
-7,669
-31% -$221K ﹤0.01% 1372
2018
Q3
$1.08M Buy
24,361
+4,920
+25% +$218K 0.01% 1092
2018
Q2
$1.14M Buy
+19,441
New +$1.14M 0.01% 1060